Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes

Completed · Phase 3

Conditions studied: Diabetes, Hypertension, Dyslipidemia

In brief

Our study intends to test the efficacy of pharmacist-led group interventions on a weekly basis for 4-weeks, then on a monthly basis for 5 additional months to achieve concomitant reductions in hemoglobin A1c, lipids and blood pressure.

Key facts

Study ID

NCT00409240

Run by

Providence VA Medical Center

People needed

103

Starts

2006-10-01

Expected to finish

2008-06-01

Last updated by the study team

2014-04-11

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• type 2 diabetes mellitus,
• >18 years old,
• with a documented HbA1c more than 7.0%,
• an LDL cholesterol >100 mg/dl AND a blood pressure >130/80 mm Hg documented at least once in the medical records within the last 6 months, and
• willing to comply with the study interventions will be eligible for the study.

You may not qualify if…

• pregnancy,
• unable to attend the group sessions,
• disease conditions such as psychiatric instability (acutely suicidal, psychotic) or organic brain injury that preclude them from performing diabetes self-care,
• enrolled in the Providence VAMC's Telehealth program

Where it is running

• Providence VAMC — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.